Navigation Links
IRIDEX Announces Global Distribution and Supply Agreement with Peregrine Surgical, Ltd.
Date:4/2/2013

MOUNTAIN VIEW, Calif., April 2, 2013 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) today announced that it has entered into a global distribution and supply agreement with Peregrine Surgical, Ltd., a privately held company based in New Britain, Pennslvania.  Under the agreement, IRIDEX will become a worldwide distributor for Peregrine labeled products and Peregrine Surgical will become part of the IRIDEX supply chain for the manufacture of certain IRIDEX products.  

"IRIDEX has been a long time provider of proprietary, consumable ophthalmology surgical instruments such as laser EndoProbe® Handpieces and GreenTip cannulas," said Will Moore , President and CEO of IRIDEX. "Part of our growth strategy is to broaden this portfolio of consumable products to meet the growing therapeutic demands of both hospitals and ambulatory surgery centers.  Peregrine is an ideal partner to assist IRIDEX in not only broadening our channel offering and driving costs out of our supply chain, but we anticipate our partnership will also accelerate product development cycles for new disposable products."

"Peregrine Surgical has invested in establishing high quality and efficient manufacturing of surgical instruments," stated Todd Richmond , President of Peregrine Surgical.  Mr. Richmond further stated, "The global reach of IRIDEX will represent a mutually beneficial partnering for the brand names of both companies."

This arrangement involves IRIDEX assuming management of Peregrine Surgical's independent distribution channel in the US and IRIDEX anticipates introducing Peregrine's products to its OUS channels in the near future.  The integration should provide additional coverage and leverage for both company's product lines.

About IRIDEX

IRIDEX Corporation was founded in 1989 and is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market. We maintain a deep commitment to the success of our customers, with comprehensive technical, clinical, and service support programs. IRIDEX is dedicated to a standard of excellence, offering superior technology for superior results. IRIDEX products are sold in the United States through a direct sales force and internationally through a combination of a direct sales force and a network of approximately 70 independent distributors into over 100 countries. For further information, visit the IRIDEX website at http://www.iridex.com/.

Safe Harbor Statement

This announcement contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Act of 1934, as amended, relating to the markets for the Company's products and the anticipated benefits of the Company's relationship with Peregrine Surgical, Ltd.  These statements are not guarantees of future performance and actual results may differ materially from those described in these forward-looking statements as a result of a number of factors.  Please see a detailed description of these and other risks contained in our Annual Report on Form 10-K for the fiscal year ended December 31, 2011, and our Quarterly Reports on Form 10-Q for the fiscal quarters ended March 31, 2012, June 30, 2012, and September 29, 2012, each of which was filed with the Securities and Exchange Commission. Forward-looking statements contained in this announcement are made as of this date and will not be updated.


'/>"/>
SOURCE IRIDEX Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. IRIDEX Reports Record 2012 Fourth Quarter Results
2. IRIDEX Announces Fourth Quarter and Full Year 2012
3. IRIDEX Announces Preliminary Unaudited Revenues for 2012 Fourth Quarter and Year End
4. IRIDEX Corporation Announces Preliminary Results of its Tender Offer
5. IRIDEX Announces FDA 510(k) and CE Clearance of New Laser Delivery System for Fast, Non-invasive Treatment of Serious Retinal Diseases
6. QUANTEL Medical Signs Global Licensing Agreement with IRIDEX
7. IRIDEX Announces Tender Offer to Purchase up to 487,500 Shares of its Common Stock
8. IRIDEX Reports 2012 Third Quarter Results
9. IRIDEX Announces Third Quarter 2012 Conference Call and Release Date
10. IRIDEX Appoints Chairman William M. Moore as Interim President & CEO
11. IRIDEX Reports 2012 Second Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... 2016 RnRMarketResearch.com adds "Asthma - ... analysis of Asthma therapy at various stages, therapeutics assessment ... administration (RoA) and molecule type, along with latest updates, ... key players involved in the therapeutic development for Asthma ... Complete report on H1 2016 pipeline review of ...
(Date:5/30/2016)... 2016 According to a ... Market by Type (Stability, Raw Materials, Method Validation, ... (Pharmaceutical Companies, Medical Device Companies) - Global Forecast ... healthy growth during the last decade and is ... between 2016 and 2021 to reach USD 4.13 ...
(Date:5/30/2016)... - DCGI grants limited approval to market Stempeucel® product for ... Stempeucel® becomes 5th off-the-shelf Stem cell product to be approved by ... Disease (also known as Thromboangiitis Obliterans) is a major unmet medical ... - Prevalence of Buerger,s Disease is estimated to be 1,000,000 in ... the European Community & USA ...
Breaking Medicine Technology:
(Date:5/31/2016)... ... ... The Global Wellness Summit (GWS), an annual conference for international ... travel, spa and beauty in Europe. The organization asked its partner experts in Europe ... researchers - to forecast where wellness is headed in Europe. Predictions range from European ...
(Date:5/31/2016)... (PRWEB) , ... May 31, 2016 , ... The Orthopaedic ... executive committee members: , David G. Lewallen, MD, began his term as president ... president. Michael L. Parks, MD, is OREF’s new president-elect. Richard F. Kyle, MD, will ...
(Date:5/31/2016)... , ... May 31, 2016 , ... In a recent ... Feiner and broadcast on New Rochelle, NY-based WVOX (1460 AM), leading medical ... what she calls the country’s “modern medical money maelstrom.” , During the interview ...
(Date:5/31/2016)... ... May 31, 2016 , ... To meet a growing demand ... industry, The University of Scranton is adding a Certificate in Health Informatics to ... in rapidly growing field of healthcare information. , Healthcare organizations are under ...
(Date:5/30/2016)... , ... May 30, 2016 , ... ... use inside of FCPX," said Christina Austin - CEO of Pixel Film Studios. ... use within Final Cut Pro X. Choose from abstract transitions to more simple ...
Breaking Medicine News(10 mins):